As the need to reduce the high burden of preventable disease and premature death experienced by racial and ethnic minorities increases, recognizing and managing bias becomes an important clinical concern, one that no provider can afford to ignore.

Excerpted from FDA News Release, dated March 9, 2011 The US Food and Drug Administration…